Upgrade to SI Premium - Free Trial

Neovasc (NVCN) Announces First Implant of its Reducer in U.S. Patient

June 20, 2018 7:34 AM
Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News Management Comments

Next Articles